The triple therapy of metformin, a DPP-4 inhibitor and a SGLT-2 inhibitor has a very low treatment related hypoglycaemia risk, leads to a further, almost additive reduction of glycaemic parameters, a body weight loss in the same range as with a mono- or dual therapy with a SGLT-2 inhibitor and also to the expected SGLT-2 inhibitor induced reduction of blood pressure
This product must not be administered to humans or animals
LIPOSOMAL GLUTATHIONE Supports the body's natural detox process Powerful antioxidant properties Helps maintain immune health Promotes clearer, radiant skin Notice results in just two weeks Most Detox Supplements Just Flush and Forget
Glutamine as indispensable nutrient in oncology: experimental and clinical evidence
Melanin: the biophysiology of oral melanocytes and physiological oral pigmentation.Head & Face Medicine
With IV therapy, what goes into your bloodstream and who administers it directly affects your safety and results